Redcare Pharmacy NV Stock

Equities

RDC

NL0012044747

Drug Retailers

Market Closed - Xetra 11:38:04 2024-05-23 am EDT 5-day change 1st Jan Change
105.7 EUR +4.24% Intraday chart for Redcare Pharmacy NV -11.92% -19.68%
Sales 2024 * 2.38B 2.58B Sales 2025 * 2.91B 3.15B Capitalization 2.15B 2.33B
Net income 2024 * -7M -7.57M Net income 2025 * 41M 44.33M EV / Sales 2024 * 0.97 x
Net Debt 2024 * 162M 175M Net Debt 2025 * 143M 155M EV / Sales 2025 * 0.79 x
P/E ratio 2024 *
-288 x
P/E ratio 2025 *
58.5 x
Employees 1,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.24%
1 week-11.92%
Current month-16.77%
1 month-19.31%
3 months-24.93%
6 months-13.64%
Current year-19.68%
More quotes
1 week
95.60
Extreme 95.6
120.40
1 month
95.60
Extreme 95.6
140.10
Current year
95.60
Extreme 95.6
153.00
1 year
81.64
Extreme 81.64
153.00
3 years
36.51
Extreme 36.51
182.00
5 years
28.30
Extreme 28.3
249.00
10 years
24.00
Extreme 24
249.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 23-07-31
Director of Finance/CFO 51 20-01-31
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 52 15-12-31
Founder 60 00-12-31
Director/Board Member 53 22-04-13
More insiders
Date Price Change Volume
24-05-23 105.7 +4.24% 203,386
24-05-22 101.4 +3.47% 176,490
24-05-21 98 -10.99% 449,831
24-05-20 110.1 +0.55% 46,064
24-05-17 109.5 -9.13% 252,314

Delayed Quote Xetra, May 23, 2024 at 11:38 am EDT

More quotes
Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
105.7 EUR
Average target price
149.4 EUR
Spread / Average Target
+41.36%
Consensus